Dihydroergotamine Mesylate Spray, Metered
Product Images NDC 70069-880

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dihydroergotamine Mesylate (NDC 70069-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 01)

Chemical structure of dihydroergotamine mesylate, labeled with its molecular formula C33H37N5O5·CH4O3S and molecular weight 679.80.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 02)

Line graph showing the estimated probability over 4 hours of a patient responding to a 2 mg dose of Dihydroergotamine Mesylate Nasal Spray versus placebo. The vertical axis represents the estimated probability of response to study medication (%), and the horizontal axis shows time from first dose (hours). Two lines depict higher response probability with Dihydroergotamine Mesylate compared to placebo over time.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 03)

A line graph showing the estimated probability of a patient responding to Dihydroergotamine Mesylate nasal spray versus placebo during the first four hours after dosing. The x-axis represents time in hours from first dose, and the y-axis shows the estimated probability of response to study medication. The Dihydroergotamine Mesylate group exhibits a higher response probability over time compared to placebo.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 04)

A line graph illustrating the estimated probability of patients using additional treatments for migraine over 24 hours following administration of Dihydroergotamine Mesylate Nasal Spray 2 mg or placebo. The x-axis represents hours after first spray (0 to 24), and the y-axis shows estimated probability percentage (0% to 100%). Two lines compare Dihydroergotamine Mesylate and placebo groups, showing higher additional treatment use in the placebo group over time.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 05)

DIHYDROERGOTAMINE MESYLATE nasal spray 4 mg/mL (1 mL vial) label shows this metered nasal spray for prescription use only. The label notes it is for nasal use only and not for injection. Manufactured for Somerset Therapeutics, LLC in Somerset, NJ. The label includes the NDC 70069-880-01 and a barcode, stating the product is made in Italy.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 06)

Packaging label for DIHYDROERGOTAMINE MESYLATE nasal spray, 4 mg/mL strength, including 1 vial and 1 sprayer. The label indicates the product is for nasal use only, not for injection or individual sale, and is manufactured for Somerset Therapeutics, LLC. It provides storage instructions and states it is a prescription-only human drug.*

FDA Label Image

Image (8d88a6e3 0b91 4414 Acce 4de8bb371ac1 07)

Packaging label for DIHYDROERGOTAMINE MESYLATE nasal spray, 4 mg/mL (1 mL per vial), manufactured for Somerset Therapeutics, LLC. The label states 'Rx only' and indicates the product is for nasal use only, not for injection. The kit contains 8 vials and 8 nasal sprayers, along with administration instructions and a package insert. Storage instructions note to store below 25°C and not to refrigerate or freeze. The NDC number 70069-880-08 is displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.